Vaccination of healthy subjects and autoantibodies: From mice through dogs to humans

Lupus

Volumn 18, Issue 13, 2009, Pages 1186-1191

  Toplak, Nataša ^a   Avcin T ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

Author keywords

Antiphospholipid antibodies; Autoantibodies; Healthy subjects; Vaccination

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BCG VACCINE; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA POLIOMYELITIS TETANUS VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; PHOSPHOLIPID ANTIBODY;

ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; DOG; HUMAN; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINATION;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; DOG DISEASES; DOGS; HUMANS; MICE; VACCINATION;

EID: 71049125221     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309346975     Document Type: Review

References (31)

1. Molina V., Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 2005; 38: 235-245.
2. Avcin T., Toplak N. Antiphospholipid antibodies in response to infection. Curr Rheumatol Rep 2007; 9: 212-218.
3. Tishler M., Shoenfeld Y. Vaccination may be associated with autoimmune diseases. IMAJ 2004; 6: 430-432.
4. Atassi MZ, Casali P. Molecular mechanisms of autoimmunity. Autoimmunity 2008; 41: 123-132.
5. Gineli PJ, Lucena R. Investigation of antinuclear antibodies in canine atopic dermatitis. J Vet Med A Physiol Pathol Clin Med 2001; 48: 193-198.
6. Papini R., Pellegrini O., Guidi G. Anticardiolipin antibodies in healthy and diseased dogs. Vet Rec 2005; 4: 156: 732-734.
7. Hilario MO, Len CA, Roja SC, Terreri MT, Almeida G., Andrade LE Frequency of antinuclear antibodies in healthy children and adolescents. Clin Pediatr 2004; 43: 637-642.
8. McGhee JL, Kickingbird LM, Jarvis JN Clinical utility of antinuclear antibody tests in children. BMC Pediatr 2004; 4: 13.
9. Tan EM, Feltkamp TE, Smolen JS, et al. Range of antinuclear antibodies in healthy individuals. Arthritis Rheum 1997; 40: 1601-1611.
10. Laustrup H., Heegaard N., Voss A., Green A., Lillevang ST, Junker P. Autoantibodies and self-reported health complaints in relatives of systemic lupus erythematosus patients: A community based approach. Lupus 2004; 13: 792-799.
11. Fields RA, Toubbeh H., Searles RP, Bankhurst AD The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies. J Rheumatol 1989; 16: 623-625.
12. Prelog M. Aging of the immune system: A risk factor for autoimmunity? Autoimmun Rev 2006; 5: 136-139.
13. Avcin T., Ambrozic A., Kuhar M., Kveder T., Rozman B. Anticardiolipin and anti-beta2 glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. Rheumatology 2001; 40: 565-573.
14. Hogenesch H., Azcona-Olivera J., Scott-Montcrieff C., Snyder PW, Glickman LT Vaccine induced autoimmunity in the dog. Adv Vet Med 1999; 41: 733-747.
15. Scott-Moncrieff JC, Azcona-Olivera J., Glickman NW, Glickman LT, Hogenesch H. Evaluation of antithyroglobulin antibodies after routine vaccination in pet and research dogs. J Am Vet Med Assoc 2002; 221: 515-521.
16. Blank M., Krause I., Fridkin M., et al. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 2002; 109: 797-804.
17. Stojanović M., Živković I., Inić Kanda A., Petrušić V., Mićič M., Dimitrijević L. The context of tetanus toxoid application influences the outcome of antigen-specific and self-directed humoral immune response. Microbiol Immunol 2009; 53: 89-100.
18. Kelly KM, Kuroda Y., Nacionales DC, Akaogi J., Satoh M., Reeves W. Induction of autoimmunity by adjuvant hydrocarbons. In: Shoenfeld Y, Rose NR (eds), Infection and autoimmunity. Amsterdam: Elsevier; 2004. p. 87-104.
19. Martinuč Porobič J., Avčin T., Božič B., et al. Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine. Clin Exp Immunol 2005; 142: 377-380.
20. Toplak N., Kveder T., Trampuš-Bakija A., Šubelj V., Čučnik S., Avčin T. Autoimmune response following annual influenza vaccination in 92 apparently healthy adults. Autoimmun Rev 2008; 8: 134-138.
21. Aron-Maor A., Shoenfeld Y. In: Shoenfeld Y, Rose NR (eds), Infection and autoimmunity. Amsterdam: Elsevier; 2004. p. 105-116.
22. Altman A., Szyper-Kravitz M., Shoenfeld Y. HBV vaccine and dermatomyositis: Is there an association? Rheumatol Int 2008; 28: 609-612.
23. Haber P., DeStefano F., Angulo FJ, et al. Guillain-Barré syndrome following influenza vaccination. JAMA 2004; 24: 2478-2481.
24. Mormile R., D'Alterio V., Treccagnoli G., Sorrentino P. Henoch-Schonlein purpura with antiphospholipid antibodies after influenza vaccination: how fearful is it in children? Vaccine 2004; 23: 567-568.
25. Watanabe T., Onda H. Henoch-Schönlein purpura with antiphospholipid antibodies following influenza vaccination. Pediatr Nephrol 2001; 16: 458-459.
26. Blank M., Barzilai O., Shoenfeld Y. Molecular mimicry and autoimmunity. Clin Rev Allergy Immunol 2007; 32: 111-118.
27. Marks DJB, Mitchison NA, Segal AW, Sieper J. Can unresolved infection precipitate autoimmune disease? Curr Top Microbiol Immunol 2006; 305: 105-125.
28. Pisetsky DS The role of innate immunity in the induction of autoimmunity. Autoimmun Rev 2008; 8: 69-72.
29. Jamin C., Morva A., Lemoine S., Daridon C., deMendoza AR, Youinou P. Regulatory B lymphocytes in humans. Arthritis Rheum 2008; 58: 1900-1906.
30. Heer AK, Shamshiev A., Donda A., et al. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J Immunol 2007; 178: 2182-2191.
31. Vial T., Choquet-Kastylevsky G., Descotes J. Adverse effects of immunotherapeutics involving the immune system. Toxicology 2002; 174: 3-11.